Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Takeda
Sort By
Newest First
1 / 2
1 / 2
Cell Therapy Capacity
Takeda Opens New R&D Cell Therapy Manufacturing Facility to Support Expansion of Next-Generation Clinical Programs
Takeda
PR-M09-20-NI-17-1291
Sep 15, 2020
Sales
Takeda to Sell OTC Drug Unit to Blackstone for $2.3bn
Takeda
PR-M08-20-NI-33
Aug 19, 2020
Drug Development
Neurocrine Biosciences and Takeda Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders
Takeda
PR-M06-20-NI-019
Jun 16, 2020
Licensing Agreement
ProThera Biologics and Takeda Develop Novel Plasma-Derived Therapy Based on Inter-alpha Inhibitor Proteins
Takeda
PR-M04-20-NI-034
Apr 24, 2020
Recall
Takeda Issues US Recall of Two Lots of VONVENDI
Takeda
PR-M02-20-NI-038
Feb 27, 2020
Diagnostics
Takeda and Enzyre to Develop Diagnostic Device Allowing Hemophilia Patients to Determine their Coagulation Status at Home
Takeda
PR-M12-19-NI-009
Dec 06, 2019
Divest
Takeda Agrees to Divest Select OTC and Non-core Assets to Acino for Over $200 Million USD
Takeda
PR-M10-19-NI-021
Oct 15, 2019
Business
Takeda Looks to Sell European Assets
Nice Insight
PAO-M08-19-NI-009
Aug 07, 2019
CSR
Takeda Selects Five New Partnerships for Annual Global Corporate Social Responsibility (CSR) Program
Takeda
PR-M07-19-NI-008
Jul 05, 2019
Divestiture
Takeda Slimming Down
Nice Insight
PAO-M05-19-NI-018
May 21, 2019
Collaboration
Takeda and Frazier Healthcare Partners Announce Collaboration to Launch Phathom Pharmaceuticals
Takeda
PR-M05-19-NI-058
May 21, 2019
Announcement
Takeda Opens New Global Research Center in San Diego
Takeda
PR-M05-19-NI-010
May 03, 2019
Cell and Gene Therapy
Takeda Collaborates on Gene Therapy Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M04-19-NI-003
Apr 02, 2019
Partnership
Takeda and HemoShear Therapeutics Extend Exclusive Drug Discovery Partnership in Liver Diseases
HemoShear Therapeutics
PR-M03-19-NI-059
Mar 21, 2019
Real World Data
New Real-World Data Analyses Support the Long-Term Use of Entyvio® (vedolizumab) in Bio-Naïve Patients for the Treatment of Moderate to Severe Ulcerative Colitis or Crohn's Disease
Takeda
PR-M10-18-NI-034
Oct 10, 2018
Strategic Collaboration
Crescendo Biologics Reaches Technical Milestone for a Second Target in Strategic Collaboration with Takeda
Crescendo Biologics
PR-M09-18-NI-035
Sep 13, 2018
Partnership
Ambys Medicines and Takeda Announce Partnership to Pioneer First-in-Class Therapies for the Treatment of Serious Liver Diseases
Cytotheryx
PR-M08-18-NI-081
Aug 21, 2018
Acquisition
Takeda Acquires Shire for $62 Billion
Emilie Branch
Pharma's Almanac
PAO-M05-18-NI-005
May 10, 2018
Prescribing Information
TRINTELLIX® Prescribing Information Now Includes New Data Showing Improvement in Processing Speed
Takeda
PR-M05-18-NI-027
May 08, 2018
Immuno-Oncology
FIMECS, Inc. Concludes Licensing Agreement with Takeda to Develop Novel Immuno-Oncology Therapies
FIMECS, Inc.
PR-M04-18-NI-44
Apr 13, 2018
